Patent · US Active

Substituted perhydropyrrolo[3,4-c]pyrrole derivatives and the use of same

US10414765B2 · kind B2 · utility

4Cited by

4References

8Claims

0Family size

Assignee

Bayer Pharma Aktiengesellschaft · DE

Inventors

Martina Delbeck · Essen, DE
Michael Hahn · Langenfeld, DE
Thomas Müller · Bonn, DE
Heinrich Meier · Wuppertal, DE
Klemens Lustig · Wuppertal, DE
Johanna Mosig · Dortmund, DE
Luisella Toschi · Berlin, DE
Udo Albus · Florstadt, DE
Doris Gehring · Kelkheim, DE
Björn Rosenstein · Salmünster, DE

Key dates

Filing date	Dec 2, 2016
Grant date	Sep 17, 2019
Priority date	—
Expiry date	Dec 2, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D519/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present application relates to novel (2-phenylimidazo[1,2-a]pyridin-3-yl)methyl-substituted perhydropyrrolo[3,4-c]pyrrole derivatives, to methods for the preparation thereof, to the use thereof alone or in combinations for treatment and/or prevention of diseases, and to the use thereof for production of medicaments for treatment and/or prevention of diseases, especially for treatment and/or prevention of respiratory disorders including sleep-related respiratory disorders such as obstructive sleep apneas and central sleep apneas and snoring.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.